Literature DB >> 17658398

Current and future management of psoriasis.

Alan Menter1, Christopher Em Griffiths2.   

Abstract

Management of psoriasis begins with identification of the extent of cutaneous disease. However, a holistic, contractual approach to treatment is encouraged, with particular reference to psychosocial disability and quality-of-life issues. The presence of psoriasis on palms, soles, body folds, genitals, face, or nails, and concomitant joint disease, are also important when considering treatment options. An evidence-based approach is essential in delineating differences between the many available treatments. However, archaic approaches, especially combinational ones, are routinely used by some clinicians, with inadequate prospective or comparative evidence. Treatments currently available are: topical agents used predominantly for mild disease and for recalcitrant lesions in more severe disease; phototherapy for moderate disease; and systemic agents including photochemotherapy, oral agents, and newer injectable biological agents, which have revolutionised the management of severe psoriasis. Other innovative treatments are undergoing clinical studies, with the aim of maintaining safe, long-term control of the condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17658398     DOI: 10.1016/S0140-6736(07)61129-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  55 in total

1.  Topical delivery of a naproxen-dithranol co-drug: in vitro skin penetration, permeation, and staining.

Authors:  Wing Man Lau; Alex W White; Charles M Heard
Journal:  Pharm Res       Date:  2010-09-25       Impact factor: 4.200

2.  Enhanced epidermal localization of topically applied steroids using SPACE™ peptide.

Authors:  Sunny Kumar; Ming Chen; Aaron C Anselmo; John A Muraski; Samir Mitragotri
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

Review 3.  Angiogenesis drives psoriasis pathogenesis.

Authors:  Regina Heidenreich; Martin Röcken; Kamran Ghoreschi
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  Modelling epidermis homoeostasis and psoriasis pathogenesis.

Authors:  Hong Zhang; Wenhong Hou; Laurence Henrot; Sylvianne Schnebert; Marc Dumas; Catherine Heusèle; Jin Yang
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

5.  Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis.

Authors:  S Indhumathi; Medha Rajappa; Laxmisha Chandrashekar; P H Ananthanarayanan; D M Thappa; V S Negi
Journal:  Eur J Clin Pharmacol       Date:  2017-04-25       Impact factor: 2.953

6.  Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy.

Authors:  Atsushi Yoshida; Toshikatsu Kaburaki; Kimiko Okinaga; Mitsuko Takamoto; Hidetoshi Kawashima; Yujiro Fujino
Journal:  Jpn J Ophthalmol       Date:  2012-10-02       Impact factor: 2.447

Review 7.  Kidney disease and psoriasis: novel evidences beyond old concepts.

Authors:  Luca Visconti; Giuseppe Leonardi; Michele Buemi; Domenico Santoro; Valeria Cernaro; Carlo Alberto Ricciardi; Antonio Lacquaniti; Giuseppe Coppolino
Journal:  Clin Rheumatol       Date:  2015-11-28       Impact factor: 2.980

8.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

Review 9.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

10.  Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.